| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 25.849 | 24.354 | 16.467 | 2.783 | 1.220 | 1.440 | 1.162 |
| Total Income - EUR | - | - | - | 25.849 | 24.354 | 16.467 | 2.783 | 1.220 | 1.440 | 1.162 |
| Total Expenses - EUR | - | - | - | 9.513 | 7.629 | 9.943 | 7.989 | 200 | 5.894 | 69 |
| Gross Profit/Loss - EUR | - | - | - | 16.335 | 16.725 | 6.524 | -5.207 | 1.020 | -4.453 | 1.093 |
| Net Profit/Loss - EUR | - | - | - | 15.560 | 15.994 | 6.029 | -5.282 | 983 | -4.453 | 918 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Kub Diamedica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 1.806 | 439 | 126 | 0 | 0 | 0 |
| Current Assets | - | - | - | 25.586 | 44.226 | 56.910 | 50.589 | 15.023 | 820 | 1.665 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 1.837 | 2.481 | 1.163 | 409 | 0 | 432 | 3 |
| Cash | - | - | - | 23.748 | 41.745 | 55.747 | 50.180 | 15.023 | 388 | 1.662 |
| Shareholders Funds | - | - | - | 15.603 | 31.295 | 36.732 | 30.635 | 1.032 | -3.425 | -2.488 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 9.983 | 14.737 | 20.617 | 20.080 | 13.991 | 4.245 | 4.153 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Kub Diamedica S.r.l.